Vivo Opportunity Fund, L.P., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 750,016 shares at $22.25 ($16.7M) on 2019-03-20, disclosed to the SEC on 2019-03-25.
Open-market sale of $16.7M CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.25 | 40,407 | $899K | 5.4% |
| 2 | $22.25 | 40,407 | $899K | 5.4% |
| 3 | $22.25 | 83,984 | $1.9M | 11.2% |
| 4 | $22.25 | 292,609 | $6.5M | 39.0% |
| 5 | $22.25 | 292,609 | $6.5M | 39.0% |
| Total | $22.25 avg | 750,016 |
| $16.7M |
| 100% |
| Filing → |